Gadolinium-based contrast media may be nephrotoxic even at approved doses

Area of Science:

• Nephrology
• Radiology
• Pharmacology

Background:

• Gadolinium-based contrast media (GBCM) are widely used in Magnetic Resonance (MR) imaging.
• Current understanding suggests GBCM are safe at approved doses (<0.3 mmol/kg body weight) and not nephrotoxic.

Observation:

• A patient with diabetic nephropathy underwent MR angiography with GBCM (0.14 mmol/kg body weight gadolinium-DTPA-BMA).
• No specific precautions like hydration were administered.
• The patient developed anuria and required dialysis 6-7 days post-procedure.

Findings:

• This case demonstrates contrast medium-induced nephropathy (CMN).
• CMN occurred at a dose below 0.2 mmol/kg body weight.
• The patient had pre-existing diabetic nephropathy and slowly increasing serum creatinine levels.

Implications:

• GBCM may pose a risk of nephrotoxicity in patients with multiple risk factors, including pre-existing kidney disease.
• Lower GBCM doses may still induce nephropathy in vulnerable populations.
• Highlights the need for careful patient selection and risk assessment before GBCM administration in patients with renal impairment.